Trial intelligence / Profile preview

Evaluating efficacy of combination therapy with niosomal benzoyl peroxide and clindamycin in acne vulgaris

IRCT20170806035524N5Phase 3Completed

Sponsor
Kerman University of Medical Sciences
Start
Jun 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of benzoyl peroxide and clindamycin in acne vulgaris, sponsored by Kerman University of Medical Sciences. Started Jun 2018; status: completed.

02

Drugs

benzoyl peroxideclindamycin
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on IRCT20170806035524N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20170806035524N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call